Detail publikace

Taking advantage of ferritin disassembly for drug delivery

DOSTÁLOVÁ, S. KRAUSOVÁ, K. CHAROUSOVÁ, M. KŘÍŽKOVÁ, S. HYNEK, D. HADDAD, Y. ECKSCHLAGER, T. STIBOROVÁ, M. PEKAŘÍK, V. HEGER, Z. ADAM, V.

Originální název

Taking advantage of ferritin disassembly for drug delivery

Typ

článek ve sborníku ve WoS nebo Scopus

Jazyk

angličtina

Originální abstrakt

Many highly potent low molecular antitumor drugs suffer from severe off-target toxicity, such as the cardiotoxicity of doxorubicin (DOX) or hematological toxicity of tyrosine kinase inhibitors. Therefore, their encapsulation in nano-sized carriers able to deliver the drug molecules selectively to tumor cells, while avoiding the healthy ones, can prove beneficial. But choosing the correct material for such a nanocarrier can be a quite daunting challenge.

Klíčová slova

Antitumor Drug Delivery; Ferritin; Nanocarrier

Autoři

DOSTÁLOVÁ, S.; KRAUSOVÁ, K.; CHAROUSOVÁ, M.; KŘÍŽKOVÁ, S.; HYNEK, D.; HADDAD, Y.; ECKSCHLAGER, T.; STIBOROVÁ, M.; PEKAŘÍK, V.; HEGER, Z.; ADAM, V.

Vydáno

5. 9. 2018

ISSN

2296-9667

Periodikum

European & Global Summit for Clinical Nanomedicine and Targeted Medicine

Stát

Švýcarská konfederace

Strany od

179

Strany do

180

Strany počet

2

BibTex

@inproceedings{BUT151232,
  author="Simona {Dostálová} and Kateřina {Krausová} and Markéta {Charousová} and Soňa {Křížková} and David {Hynek} and Yazan Abdulmajeed Eyadh {Haddad} and Tomáš {Eckschlager} and Marie {Stiborová} and Vladimír {Pekařík} and Zbyněk {Heger} and Vojtěch {Adam}",
  title="Taking advantage of ferritin disassembly for drug delivery",
  booktitle="CLINAM 2018",
  year="2018",
  journal="European & Global Summit for Clinical Nanomedicine and Targeted Medicine",
  pages="179--180",
  issn="2296-9667"
}